MedPath

Polycaprolactone / Tricalcium Phosphate (PCL/TCP) v Titanium Orbital Implant : Randomised Trial

Phase 2
Conditions
Fractures
Enophthalmos
Diplopia
Registration Number
NCT01119144
Lead Sponsor
National University Hospital, Singapore
Brief Summary

Hypothesis: Polycaprolactone / Tricalcium Phosphate Orbital (PCL / TCP) Implant is as effective in the reconstruction of the Orbital walls as Titanium Mesh implant.

In this study we will be conducting a randomised trial to compare implants made of 2 materials for Orbital reconstruction

* Polycaprolactone / Tricalcium Phosphate (PCL / TCP)

* Titanium

Patients to be recruited :

* 80 randomised equally into the 2 groups

* age range: 21 - 70

* includes orbital wall defects from trauma, after osteotomies

* excludes patients with Diabetes Mellitus, known allergies to polycaprolactone \& its analogues, know allergies to Tricalcium Phosphate \& its analogues, infections generalised \& around the orbital region

Trial Duration: April 2010 - March 2015

Follow up:

* postoperative 1 week, 1 month, 3 months, 6 months, and 12 months

* Computer Tomographic (CT) scan of Orbits immediate postoperative and at 12 months appointment

Detailed Description

Hypothesis: Polycaprolactone / Tricalcium Phosphate (PCL / TCP) Orbital Implant is as effective in the reconstruction of the Orbital walls as Titanium Mesh

In this study we will be conducting a randomised trial to compare implants made of 2 materials for Orbital reconstruction

* Polycaprolactone / Tricalcium Phosphate (PCL / TCP)

* Titanium

Patients to be recruited :

* 80 randomised equally into the 2 groups

* age range: 21 -70

* includes orbital wall defects from trauma confirmed by Computer Tomographic (CT) scans, after osteotomies

* excludes patients with Diabetes Mellitus, known allergies to polycaprolactone \& its analogues, know allergies to Tricalcium Phosphate \& its analogues, infections generalised \& around the orbital region

Trial Duration : April 2010 - March 2015

Follow up:

* postoperative 1 week, 1 month, 3 months, 6 months, and 12 months

* Computer Tomographic (CT) scan of Orbits immediate postoperative and at 12 months appointment

* all patients will be seen \& assessed in the Plastic \& Ophthalmology outpatient clinics by Principal Investigator (PI) and collaborators

End point :

* endpoint for follow-up is 12 months

* all patients are assessed for assessed for diplopia, enophthalmos, exophthalmos, visual acuity, mobility of the globe, contour symmetry

* all patients will have a Computer Tomographic (CT) scan of the orbits at 12 months to assess the bony orbit \& orbital volume

* patients will be discharged from follow up at 12 months if asymptomatic

* patients with complications will exit the protocol \& will be treated on their merits eg. infection - removal of implant, etc

Data Management :

* maintained by the Principal Investigator (PI) under repository of the Research \& Development Office, National Healthcare Group (NHG) / National University Health Systems (NUHS), Singapore

* no data will be released without the permission of the Principal Investigator (PI) \& the Research \& Development Office, National Healthcare Group (NHG) / National University Health Systems (NUHS), Singapore

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • age 21 y - 70 y
  • both males / females included
  • orbital fractures
  • defect after orbital osteotomies
Exclusion Criteria
  • patient refusal
  • infection around the orbit / generalised infection
  • Diabetes mellitus
  • allergies to polycaprolactone & its analogues
  • allergies to titanium

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Enophthalmos1 year

Assess the presence of enophthalmos after reconstruction of the orbital walls at 1 week, 1 month, 3 months, 6 months and 12 months

Secondary Outcome Measures
NameTimeMethod
Diplopia1 year

Assess the evidence of diplopia on follow up at 1 week, 1 month, 3 months, 6 months and 12 months

motility of the globe1 year

assess globe motility on follow up at 1 week, 1 month, 3 months, 6 months, and 12 months

Trial Locations

Locations (1)

National University Hospital

🇸🇬

Singapore, Singapore

National University Hospital
🇸🇬Singapore, Singapore
Thiam Chye Lim
Contact
surlimtc@nus.edu.sg
Eileen Hing
Contact
surhch@nus.edu.sg
Thiam Chye Lim, FRCS
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.